Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Recently Approved Breakthrough Therapies and New Approval Endpoints

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 10 of 10
Recently Approved Breakthrough Therapies and New Approval Endpoints
Chairperson
Ashley F Ward
FDA, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:15 PM
Recently Approved Breakthrough Therapies and New Approval Endpoints
Invited Speaker
Najat Bouchkouj
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:15 PM
Recently Approved Breakthrough Therapies and New Approval Endpoints
Invited Speaker
Dow-Chung Chi
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:15 PM
Recently Approved Breakthrough Therapies and New Approval Endpoints
Invited Speaker
Noelle Frey
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:15 PM
Recently Approved Breakthrough Therapies and New Approval Endpoints
Invited Speaker
Mark J. Levis
Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:15 PM
Recently Approved Breakthrough Therapies and New Approval Endpoints
Invited Speaker
Matthew R Smith
Massachusetts General Hospital Cancer Center, Boston, MA, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:15 PM
Recently Approved Breakthrough Therapies and New Approval Endpoints
Invited Speaker
Emily Jen
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:15 PM
Recently Approved Breakthrough Therapies and New Approval Endpoints
  •  
  • Permission not
    granted for presentation
  •  
  •  
Invited Speaker
Christopher S. Hourigan
NHLBI, Bethesda, MD, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:15 PM
Recently Approved Breakthrough Therapies and New Approval Endpoints
FDA Approval of Midostaurin: Improved Survival, But Does Maintenance Matter
Ashley F Ward
FDA, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:15 PM
Recently Approved Breakthrough Therapies and New Approval Endpoints
Panel Discussion
Ashley F Ward
FDA, Silver Spring, MD, United States
Najat Bouchkouj
U.S. Food and Drug Administration, Silver Spring, MD, United States
Dow-Chung Chi
U.S. Food and Drug Administration, Silver Spring, MD, United States
Noelle Frey
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
Mark J. Levis
Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, United States
Matthew R Smith
Massachusetts General Hospital Cancer Center, Boston, MA, United States
Emily Jen
U.S. Food and Drug Administration, Silver Spring, MD, United States
Christopher S. Hourigan
NHLBI, Bethesda, MD, United States
from AACR Annual Meeting 2018 on April 17, 2018 10:30 AM-12:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 10 of 10